Congress Eyes Vaccine Pricing With Spotlight On Pfizer As COVID Boosters Look More Likely

Senate hearing offers early signals that US lawmakers will be closely watching how COVID-19 vaccine pricing evolves. Biden team pledges to try to make contracting more transparent.

US Sen. Chris Murphy, D-Conn, raised concerns that the prices of COVID-19 vaccines could soon rise, becoming unfavorable to Americans just as the country is in need of booster shots and vaccinations for children, drawing particular attention to Pfizer Inc. statements on its pricing plans.

Murphy, speaking at a 18 March Senate Health Committee hearing on the country’s pandemic response, also pushed for more transparency...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Vaccines

More from Pink Sheet